• Navigation überspringen
  • Zur Navigation
  • Zum Seitenende
Organisationsmenü öffnen Organisationsmenü schließen
Logo Biochemie
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Medizinische Fakultät
Suche öffnen
  • Mein Campus
  • StudOn
  • UnivIS
  1. Friedrich-Alexander-Universität
  2. Medizinische Fakultät

Logo Biochemie

Menu Menu schließen
  • Startseite
  • Forschung
    • AG Bosserhoff (Lehrstuhl 1)
    • AG Wegner (Lehrstuhl 2)
    • AG Enz
    • AG Hellerbrand
    • AG Karow
    • AG Lie
    • AG Sticht
    • AG Beckervordersandforth
    • AG Falk
    • AG Dietrich
    • AG Hashemolhosseini
    • AG Kuphal
    • AG Küspert
    • AG Sagner
    • AG Sock
    • AG Becker
    • AG Hannappel
    Übersicht Forschung
  • Studium
  • Mitarbeiter
  1. Startseite
  2. Forschung
  3. AG Dietrich
  4. Publikationen

Publikationen

Bereichsnavigation: Forschung
  • AG Bosserhoff (Lehrstuhl 1)
  • AG Wegner (Lehrstuhl 2)
  • AG Enz
  • AG Hellerbrand
  • AG Karow
  • AG Lie
  • AG Sticht
  • AG Dietrich
    • Publikationen
  • AG Falk
  • AG Beckervordersandforth
  • AG Hashemolhosseini
  • AG Kuphal
  • AG Küspert
  • AG Becker
  • AG Sagner
  • AG Hannappel
  • AG Sock

Publikationen

  • Plechschmidt J., Fietkau K., Hepp T., Dietrich P., Fischer S., Krebs S., Neurath M., Dörje F., Atreya R.:
    Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
    In: Inflammatory Bowel Diseases 31 (2025), S. 77-86
    ISSN: 1078-0998
    DOI: 10.1093/ibd/izae040

  • Dorner H., Stolzer I., Mattner J., Kaminski S., Leistl S., Edrich LM., Schwendner R., Hobauer J., Sebald ATE., Leikam S., Gonzalez Acera M., Düll M., Lang R., Seidel G., Seitz T., Hellerbrand C., Fuhrmann G., Distler U., Tenzer S., Eichhorn P., Vieth M., Schramm C., Arnold P., Becker C., Weidinger C., Siegmund B., Atreya R., Leppkes M., Naschberger E., Sampaziotis F., Dietrich P., Rauh M., Wirtz S., Kremer A., Neurath M., Günther C.:
    Gut Pathobiont–Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis–Associated Inflammatory Bowel Disease
    In: Gastroenterology (2024)
    ISSN: 0016-5085
    DOI: 10.1053/j.gastro.2024.06.032
  • Fischer S., Donhauser M., Cohnen SE., Fietkau K., Vetter M., Grübel-Liehr M., Dietrich P., Rath T., Wilfer A., Sologub L., Krebs S., Dörje F., Nagore D., Meyer S., Neurath M., Atreya R.:
    Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study
    In: Therapeutic Advances in Gastroenterology 17 (2024)
    ISSN: 1756-283X
    DOI: 10.1177/17562848241301887

  • Ortiz C., Klein S., Reul WH., Magdaleno F., Groeschl S., Dietrich P., Schierwagen R., Uschner FE., Torres S., Hieber C., Meier C., Kraus N., Tyc O., Brol M., Zeuzem S., Welsch C., Poglitsch M., Hellerbrand C., Alfonso-Prieto M., Mira F., Keller UAD., Tetzner A., Moore A., Walther T., Trebicka J.:
    Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
    In: Cell Reports 42 (2023)
    ISSN: 2211-1247
    DOI: 10.1016/j.celrep.2023.112059
  • Payani E., Börner N., Kolliogiannis D., Brunner S., Klein I., Ehmer U., Denk G., Lange CM., Ograja K., Dietrich P., Werner J., Guba M.:
    Regional transplant rates depend more on physician-dependent variables than on proximity to transplant center
    In: Langenbecks Archives of Surgery 408 (2023), Art.Nr.: 191
    ISSN: 1435-2443
    DOI: 10.1007/s00423-023-02874-9
  • Sommer J., Ehnis H., Seitz T., Schneider J., Wild A., Moceri S., Buechler C., Bozec A., Weber G., Merkel S., Beckervordersandforth R., Steinkasserer A., Schüle R., Trebicka J., Hartmann A., Boßerhoff AK., von Hörsten S., Dietrich P., Hellerbrand C.:
    Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity
    In: International Journal of Molecular Sciences 24 (2023), Art.Nr.: 14943
    ISSN: 1422-0067
    DOI: 10.3390/ijms241914943

  • Düll M., Karlen V., Vetter M., Dietrich P., Kupfer J., Neurath M., Kremer A.:
    Chronic pruritus represents a major burden in non-cholestatic hepatobiliary disorders
    In: JOURNAL OF HEPATOLOGY, AMSTERDAM: 2022
    DOI: 10.1016/s0168-8278(22)00705-x
  • Seitz T., John N., Sommer J., Dietrich P., Thasler WE., Hartmann A., Evert K., Lang SA., Boßerhoff AK., Hellerbrand C.:
    Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
    In: International Journal of Molecular Sciences 23 (2022), Art.Nr.: 11524
    ISSN: 1422-0067
    DOI: 10.3390/ijms231911524
  • Simon D., Tascilar K., Fagni F., Kleyer A., Krönke G., Meder C., Dietrich P., Orlemann T., Mößner J., Taubmann J., Mutlu MY., Knitza J., Kemenes S., Liphardt AM., Schönau V., Bohr D., Schuster L., Minopoulou I., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G., Hartmann F.:
    Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.
    In: The Lancet Rheumatology 4 (2022), S. e614-e625
    ISSN: 2665-9913
    DOI: 10.1016/S2665-9913(22)00191-6
  • Simon D., Tascilar K., Kleyer A., Fagni F., Krönke G., Meder C., Dietrich P., Orlemann T., Kliem T., Moessner J., Liphardt AM., Schönau V., Bohr D., Schuster L., Hartmann F., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G.:
    Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort
    In: Arthritis and Rheumatology (2022)
    ISSN: 2326-5191
    DOI: 10.1002/art.42035
  • Tascilar K., Simon D., Kleyer A., Fagni F., Krönke G., Meder C., Dietrich P., Orlemann T., Kliem T., Moessner J., Liphardt AM., Schönau V., Bohr D., Schuster L., Hartmann F., Taubmann J., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G.:
    LONG-TERM HUMORAL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE
    In: ANNALS OF THE RHEUMATIC DISEASES, LONDON: 2022
    DOI: 10.1136/annrheumdis-2022-eular.5079

  • Düll M., Wolf K., Vetter M., Dietrich P., Neurath M., Kremer A.:
    Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus
    In: Frontiers in Medicine 8 (2021), Art.Nr.: 641163
    ISSN: 2296-858X
    DOI: 10.3389/fmed.2021.641163
  • Fritz V., Malek L., Gaza A., Wormser L., Appel M., Kremer A., Thasler WE., Neurath M., Hellerbrand C., Boßerhoff AK., Dietrich P., Siebler J.:
    Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma
    In: Cancers 13 (2021), S. 1-14
    ISSN: 2072-6694
    DOI: 10.3390/cancers13051183
  • Gaza A., Fritz V., Malek L., Wormser L., Treiber N., Danner J., Kremer AE., Thasler WE., Siebler J., Meister G., Neurath MF., Hellerbrand C., Boßerhoff AK., Dietrich P.:
    Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
    In: Neoplasia 23 (2021), S. 502-514
    ISSN: 1522-8002
    DOI: 10.1016/j.neo.2021.04.001
  • Seitz T., Hackl C., Freese K., Dietrich P., Mahli A., Thasler RM., Thasler WE., Lang SA., Boßerhoff AK., Hellerbrand C.:
    Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of melanoma cells
    In: Cancers 13 (2021), S. 1-12
    ISSN: 2072-6694
    DOI: 10.3390/cancers13030511
  • Vetter M., Dietrich P., Kremer A.:
    Therapy adaption by dose titration of obeticholic acid in a 57-year-old female patient with PBC and advanced liver fibrosis
    In: SWISS MEDICAL WEEKLY, MUTTENZ: 2021
  • Weindl L., Atreya I., Dietrich P., Neubeck S., Neurath M., Pavel ME.:
    Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms
    In: Endocrine-Related Cancer 28 (2021), S. 605-620
    ISSN: 1351-0088
    DOI: 10.1530/ERC-20-0500

  • Dietrich P., Wormser L., Fritz V., Seitz T., de Maria M., Schambony A., Kremer A., Günther C., Itzel T., Thasler WE., Teufel A., Trebicka J., Hartmann A., Neurath M., von Hörsten S., Boßerhoff AK., Hellerbrand C.:
    Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer
    In: Journal of Clinical Investigation 130 (2020), S. 2509-2526
    ISSN: 0021-9738
    DOI: 10.1172/JCI131919
  • Jefremow A., Wiesmüller M., Rouse RA., Dietrich P., Kremer A., Waldner M., Neurath M., Siebler J.:
    Beyond the border: The use of lenvatinib in advanced hepatocellular carcinoma after different treatment lines: A retrospective analysis
    In: Journal of Physiology and Pharmacology 71 (2020), S. 717-728
    ISSN: 0867-5910
    DOI: 10.26402/jpp.2020.5.11
  • Jefremow A., Wiesmüller M., Rouse RA., Dietrich P., Kremer A., Waldner M., Neurath M., Siebler J.:
    Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines
    In: ONCOLOGY RESEARCH AND TREATMENT, BASEL: 2020
  • Koch A., Ebert EV., Seitz T., Dietrich P., Berneburg M., Boßerhoff AK., Hellerbrand C.:
    Characterization of glycolysis-related gene expression in malignant melanoma
    In: Pathology Research and Practice 216 (2020), Art.Nr.: 152752
    ISSN: 0344-0338
    DOI: 10.1016/j.prp.2019.152752
  • Linck-Paulus L., Hellerbrand C., Boßerhoff AK., Dietrich P.:
    Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
    In: Cells 9 (2020)
    ISSN: 2073-4409
    DOI: 10.3390/cells9010114
  • Schierwagen R., Dietrich P., Klein S., Uschner FE., Ortiz C., Tyc O., Torres S., Hellerbrand C., Sauerbruch T., Trebicka J.:
    β-Arrestin2 is increased in liver fibrosis in humans and rodents
    In: Proceedings of the National Academy of Sciences of the United States of America 117 (2020), S. 27082-27084
    ISSN: 0027-8424
    DOI: 10.1073/pnas.2014337117
  • Seitz T., Freese K., Dietrich P., Thasler WE., Boßerhoff AK., Hellerbrand C.:
    Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
    In: Scientific Reports 10 (2020), Art.Nr.: 4546
    ISSN: 2045-2322
    DOI: 10.1038/s41598-020-61510-4
  • Simon D., Tascilar K., Krönke G., Kleyer A., Zaiss M., Heppt F., Meder C., Atreya R., Klenske E., Dietrich P., Abdullah A., Kliem T., Corte G., Morf H., Leppkes M., Kremer A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Meier C., Hueber A., Manger K., Manger B., Berking C., Tenbusch M., Überla K., Sticherling M., Neurath M., Schett G., Ramming A.:
    Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
    In: Nature Communications 11 (2020), Art.Nr.: 3774
    ISSN: 2041-1723
    DOI: 10.1038/s41467-020-17703-6
  • Simon D., Tascilar K., Krönke G., Kleyer A., Zaiss M., Heppt F., Meder C., Atreya R., Klenske E., Dietrich P., Abdullah A., Kliem T., Corte G., Morf H., Leppkes M., Kremer A., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Maier C., Hueber A., Manger K., Manger B., Berking C., Tenbusch M., Überla K., Sticherling M., Neurath M., Schett G.:
    Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
    In: ARTHRITIS & RHEUMATOLOGY, HOBOKEN: 2020

  • Dietrich P., Gaza A., Wormser L., Fritz V., Hellerbrand C., Boßerhoff AK.:
    Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
    In: Neoplasia 21 (2019), S. 257-268
    ISSN: 1522-8002
    DOI: 10.1016/j.neo.2018.11.011
  • Dietrich P., Hellerbrand C., Boßerhoff AK.:
    The delta subunit of rod-specific photoreceptor cgmp phosphodiesterase (Pde6d) contributes to hepatocellular carcinoma progression
    In: Cancers 11 (2019), Art.Nr.: 398
    ISSN: 2072-6694
    DOI: 10.3390/cancers11030398
  • Freese K., Dietrich P., Boßerhoff AK., Hellerbrand C.:
    Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma
    International Liver Congress (Vienna, 10. April 2019 - 14. April 2019)
    In: JOURNAL OF HEPATOLOGY, AMSTERDAM: 2019
    DOI: 10.1016/s0618-8278(19)30712-1
  • Freese K., Seitz T., Dietrich P., Lee SM., Thasler WE., Boßerhoff AK., Hellerbrand C.:
    Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in vitro
    In: Cancers 11 (2019), Art.Nr.: 1587
    ISSN: 2072-6694
    DOI: 10.3390/cancers11101587
  • Goeppert B., Truckenmueller F., Ori A., Fritz V., Albrecht T., Fraas A., Scherer D., Silos RG., Sticht C., Gretz N., Mehrabi A., Bewerunge-Hudler M., Pusch S., Bermejo JL., Dietrich P., Schirmacher P., Renner M., Roessler S.:
    Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
    In: Scientific Reports 9 (2019)
    ISSN: 2045-2322
    DOI: 10.1038/s41598-019-40857-3
  • Mahli A., Seitz T., Beckroege T., Freese K., Thasler WE., Benkert M., Dietrich P., Weiskirchen R., Boßerhoff AK., Hellerbrand C.:
    Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
    In: Cells 8 (2019)
    ISSN: 2073-4409
    DOI: 10.3390/cells8050457
  • Stieglitz D., Lamm S., Braig S., Feuerer L., Kuphal S., Dietrich P., Arndt S., Echtenacher B., Hellerbrand C., Karrer S., Boßerhoff AK.:
    BMP6-induced modulation of the tumor micro-milieu
    In: Oncogene 38 (2019), S. 609-621
    ISSN: 0950-9232
    DOI: 10.1038/s41388-018-0475-x

  • Riccardo Bertolo, Ithaar Derweesh, Giuseppe Simone, Michele Gallucci, Stephen Ryan, Ahmet Binday, Andrea Minervini, Marco Carini, Andrea Mari, Daniel Eun, Aryeh Keehn, Sisto Perdona, Giuseppe Quarto, James Porter, Michael Liao, Matteo Ferro, Alexandre Mottrie, Geert De Naeyer, Koon Rha, Kidon Chang, Robert Uzzo, Alexander Kutikov, David Chen, Marc Smaldone, Francesco Berardinelli, Luigi Schips, Wesley White, Bo Yang, Chao Zang, Ottavio De Cobelli, Ken Jacobsohn, Peter Langenstroer, Peter Dietrich, Prokar Dasgupta, Ben Challacombe, Nicolo De Luyk, Clayton Lau, Patrick Kilday, Jay Sulek, Chandru Sundaram, Francesco Montorsi, Alessandro Larcher, Umberto Capitanio, Inderbir Gill, Monish Aron, Akbar Ashrafi, Uzoma Anele, Lance Hampton, Gabriele Tuderti, Manuela Costantini, Riccardo Autorino, Francesco Porpiglia:
    ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR CT2 RENAL TUMORS: PERIOPERATIVE, FUNCTIONAL AND ONCOLOGICAL OUTCOMES FROM A MULTICENTER ANALYSIS (THE ROSULA PROJECT)
  • Dietrich P., Freese K., Mahli A., Thasler WE., Hellerbrand C., Boßerhoff AK.:
    Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
    In: Oncotarget 9 (2018), S. 3605-3618
    ISSN: 1949-2553
    DOI: 10.18632/oncotarget.23188
  • Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
    MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma
    In: Pigment Cell & Melanoma Research (2018)
    ISSN: 1755-1471
    DOI: 10.1111/pcmr.12698
  • Schmidt KM., Dietrich P., Hackl C., Guenzle J., Bronsert P., Wagner C., Fichtner-Feigl S., Schlitt HJ., Geissler EK., Hellerbrand C., Lang SA.:
    Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
    In: Neoplasia 20 (2018), S. 1198-1208
    ISSN: 1522-8002
    DOI: 10.1016/j.neo.2018.10.001

  • Dietrich P., Boßerhoff AK.:
    Melanoma sponge on pigmentation gene to reduce tumour-suppressive microRNAs
    In: Pigment Cell & Melanoma Research (2017)
    ISSN: 1755-1471
    DOI: 10.1111/pcmr.12660
  • Dietrich P., Koch A., Fritz V., Hartmann A., Boßerhoff AK., Hellerbrand C.:
    Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
    In: Gut (2017)
    ISSN: 0017-5749
    DOI: 10.1136/gutjnl-2017-315402
  • Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
    Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition
    In: Oncogene (2017)
    ISSN: 0950-9232
    DOI: 10.1038/onc.2017.391
  • Mahli A., Saugspier M., Koch A., Sommer J., Dietrich P., Lee S., Thasler R., Schulze-Luehrmann J., Lührmann A., Thasler WE., Müller M., Boßerhoff AK., Hellerbrand C.:
    ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
    In: Gut (2017)
    ISSN: 0017-5749
    DOI: 10.1136/gutjnl-2016-312485

  • Dietrich P., Boßerhoff AK.:
    DNMT targets MiRacle torching TORCh
    In: Pigment Cell & Melanoma Research 29 (2016), S. 399-401
    ISSN: 1755-1471
    DOI: 10.1111/pcmr.12484

  • Delic S., Thuy A., Schulze M., Proescholdt MA., Dietrich P., Boßerhoff AK., Riemenschneider MJ.:
    Systematic Investigation of CMTM Family Genes Suggests Relevance to Glioblastoma Pathogenesis and CMTM1 and CMTM3 as Priority Targets
    In: Genes Chromosomes & Cancer 54 (2015), S. 433-443
    ISSN: 1045-2257
    DOI: 10.1002/gcc.22255
  • Dietrich P., Boßerhoff AK.:
    Modifying microRNAs--another piece of the melanoma puzzle
    In: Pigment Cell & Melanoma Research 28 (2015), S. 488-9
    ISSN: 1755-1471
    DOI: 10.1111/pcmr.12389
  • Hartl J., Dietrich P., Moleda L., Mueller-Schilling M., Wiest R.:
    Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension
    In: Liver International 35 (2015), S. 2556-63
    ISSN: 1478-3223
    DOI: 10.1111/liv.12874
  • Ruedel A., Dietrich P., Schubert T., Hofmeister S., Hellerbrand C., Boßerhoff AK.:
    Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts
    In: International Journal of Clinical and Experimental Pathology 8 (2015), S. 4953-62
    ISSN: 1936-2625

  • Dietrich P., Hellerbrand C.:
    Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
    In: Best Practice & Research in Clinical Gastroenterology 28 (2014), S. 637-53
    ISSN: 1521-6918
    DOI: 10.1016/j.bpg.2014.07.008
Universität Erlangen-Nürnberg
Institut für Biochemie

Fahrstraße 17
91054 Erlangen
  • Impressum
  • Datenschutz
  • Barrierefreiheit
  • So finden Sie uns
  • Facebook
  • RSS Feed
  • Twitter
  • Xing
Nach oben